- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 112.6M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 112.7M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 113.3M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 113.4M sh |
| Shares Outstanding | Q2 2026 · Mar 31, 2026 | 111.27M sh |
| Stock Repurchased | Q2 2026 · Mar 31, 2026 | $599M |
| Stock Repurchased | Q2 2026 · Mar 31, 2025 | $232M |
| Dividends Paid | Q2 2026 · Mar 31, 2026 | $309M |
| Dividends Paid | Q2 2026 · Mar 31, 2025 | $297M |
| Capex | Q2 2026 · Mar 31, 2026 | $109M |
| Capex | Q2 2026 · Mar 31, 2025 | $99M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $554M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $563M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $2.57B |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $2.61B |
| Short Term Debt | Q2 2026 · Mar 31, 2026 | $1.12B |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $608M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $423M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $468M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $3.52B |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $3.65B |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $3.75B |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $3.45B |
| Current Assets | Q2 2026 · Mar 31, 2026 | $4.09B |
| Current Assets | Q2 2026 · Sep 30, 2025 | $3.91B |
| Total Assets | Q2 2026 · Mar 31, 2026 | $11.26B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $11.22B |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $3.10 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $5.79 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $2.22 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $3.83 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $3.11 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $5.82 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $2.22 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $3.84 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $478M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $956M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $469M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $945M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $180M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $352M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $162M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $318M |
| Net Income | Q2 2026 · Mar 31, 2026 | $350M |
| Net Income | Q2 2026 · Mar 31, 2026 | $655M |
| Net Income | Q2 2026 · Mar 31, 2025 | $252M |
| Net Income | Q2 2026 · Mar 31, 2025 | $436M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $530M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $965M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $408M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $729M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $1.13B |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $2.14B |
| Gross Profit restated | Q2 2026 · Mar 31, 2025 | $972M |
| Gross Profit restated | Q2 2026 · Mar 31, 2025 | $1.85B |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $1.11B |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $2.2B |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2025 | $1.03B |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2025 | $2.03B |
| Revenue | Q2 2026 · Mar 31, 2026 | $2.24B |
| Revenue | Q2 2026 · Mar 31, 2026 | $4.34B |
| Revenue | Q2 2026 · Mar 31, 2025 | $2B |
| Revenue | Q2 2026 · Mar 31, 2025 | $3.88B |